PCM
CPIX icon

Perritt Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Perritt Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-111,350
Closed -$501K – 266
2014
Q1 		$501K Hold
111,350
– – 0.08% 235
2013
Q4 		$569K Hold
111,350
– – 0.09% 198
2013
Q3 		$504K Buy
+111,350
New +$554K 0.1% 181

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $167M AUM 20.81% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Perritt Capital Management's CPIX Position: Q2 2014 in Review

Perritt Capital Management sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2014, closing a stake of 111,350 shares — an estimated $501K sold.

Perritt Capital Management first reported a position in CPIX in Q3 2013 and held it in 3 quarters. The position peaked at $569K in Q4 2013. 45 funds tracked by Wall St. Rank hold CPIX as of Q2 2014.

  • Perritt Capital Management reported no remaining Cumberland Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Perritt Capital Management sold 111,350 Cumberland Pharmaceuticals shares in Q2 2014, an estimated $501K.
  • Perritt Capital Management first reported a position in Cumberland Pharmaceuticals in Q3 2013 and held it in 3 quarters.
  • Perritt Capital Management's Cumberland Pharmaceuticals position peaked at $569K in Q4 2013.
  • 45 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2014.

Based on Perritt Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.